Aligos Therapeutics (ALGS) Price Target Increased by 70.91% to 67.12
28/4 06:20
The average one-year price target for Aligos Therapeutics (NasdaqCM:ALGS) has been revised to $67.12 / share. This is an increase of 70.91% from the prior estimate of $39.27 dated April 12, 2026. The price target is an average of many targets provided by analy...